Financials

  • Market Capitalization 693.69 M
  • Employee 73
  • Founded 2005
  • CEO Jason Okazaki
  • Website www.assemblybio.com
  • Headquarter Delaware, United States
  • FIGI BBG000R62Q06
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-61.84
Rapporto prezzo/fatturato
5.27

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
2706
ALLO
Allogene Therapeutics, Inc. - Common Stock
2.02 USD-3.35%-4.27%+8.60%+80.36%697.89 M USD
2710
TECX
Tectonic Therapeutic, Inc. - Common Stock
35.62 USD-2.94%-4.45%+25.95%+107.70%696.35 M USD
2718
ZVRA
Zevra Therapeutics, Inc. - Common Stock
11.57 USD-2.36%-3.42%+18.18%+8.74%687.07 M USD
2745
MDXG
MiMedx Group, Inc - Common Stock
4.50 USD-0.22%+3.21%+15.38%-35.71%655.92 M USD

Notizie